Stock Market

Eye acqusitions in US, Europe; to list in 3-5 yrs: Intas Pharma

Like this story, share it with millions of investors on M3





Eye acqusitions in US, Europe; to list in 3-5 yrs: Intas Pharma


Intas is looking at more acquisitions in US and Europe to strengthen its three main areas of operations – oral solid tablet, oncology, and differentiated patent products, the company’s MD Binish Chudgar said.